Benjamin L. Ebert, President and CEO at Dana-Farber Cancer Institute, shared Dana-Farber Cancer Institute’s post on LinkedIn:
“It was a pleasure speaking with The ASCO Post. This conversation gave me a chance to reflect on a path that started with a fascination for science and evolved into a lifelong commitment to reducing the burden of cancer.
I’ve been incredibly fortunate to learn from remarkable mentors, work alongside brilliant colleagues, and be part of a field where discovery truly changes lives.
I am proud to work with so many highly devoted and collaborative people at Dana-Farber Cancer Institute to continue advancing the science and care of cancer.”
Other articles featuring Dana-Farber Cancer Institute on OncoDaily.